|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 1650 Diagonal Road |
Address2 |
|
| City | ALEXANDRIA |
State | VA |
Zip Code | 22314 |
Country | USA |
3. Principal place of business (if different than line 2)
| City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 1386-12
|
||||||||
|
6. House ID# 321810000
|
||||||||
| TYPE OF REPORT | 8. Year | 2022 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Christopher Stewart |
Date | 7/20/2022 11:05:02 AM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
May 17, 2022, coalition comments addressed to the Federal Trade Commission regarding the pharmacy benefit manager (PBM) industry.
June 7, 2022, letter to Speaker Pelosi and Leader McCarthy expressing opposition to H.R. 6087, the "Improving Access to Workers' Compensation for Injured Federal Workers Act."
Issues pertaining to the scope of practice legislation, related to H.R. 1587/S. 1731, and in general.
Issues pertaining to prior authorization, related to H.R. 3173/S. 3018, and in general.
Issues pertaining to the Early Detection and Intervention Program, related to H.R. 5561/S. 4052, and in general.
Issues pertaining to Medicare physician reimbursement, in general.
Issues related to hearing healthcare, in general.
Issues pertaining to health information technology and electronic health records, in general.
Issues pertaining to Language Equality and Acquisition for Deaf Kids (LEAD-K) and parent choice, in general.
Issues pertaining to Graduate Medical Education, in general.
Issues pertaining to COVID-19, in general.
Issues pertaining to healthcare liability reform, in general.
Issues pertaining to healthcare practice and the Federal Supremacy Clause at the Department of Veterans Affairs, in general.
Issues related to the potential expansion of Medicare to cover hearing health benefits in potential reconciliation legislation.
Issues pertaining to the "Magnet Injury Prevention Act," H.R. 8199/S. 4479.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA), Federal Trade Commission (FTC)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Christopher |
Stewart |
|
|
|
Maura |
Farrell |
|
|
|
Thomas |
Radder |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
May 18, 2022, coalition letter addressed to CMS Administrator Chiquita Brooks-LaSure on the importance of the Appropriate Use Criteria (AUC) Program and requesting ample opportunity for stakeholder engagement with CMS.
June 27, 2022, coalition letter addressed to Chairs DeGette and Pallone, and Ranking Members Griffith and McMorris Rodgers, expressing support for H.R. 3173 and reforming the prior authorization process in the Medicare Advantage program.
Issues pertaining to the scope of practice legislation, related to H.R. 1587/S. 1731, and in general.
Issues pertaining to prior authorization, related to H.R. 3173/S. 3018, and in general.
Issues pertaining to Medicare physician reimbursement, in general
Issues related to hearing healthcare, in general.
Issues pertaining to health information technology and electronic health records, in general.
Issues pertaining to Graduate Medical Education, in general.
Issues pertaining to COVID-19, in general.
Issues related to the potential expansion of Medicare to cover hearing health benefits in Build Back Better Legislation.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Christopher |
Stewart |
|
|
|
Maura |
Farrell |
|
|
|
Thomas |
Radder |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOB
16. Specific lobbying issues
April 18, 2022, coalition letter addressed to Chair DeLauro and Ranking Member Cole advocating for increasing funding for the CDC Office on Smoking Health by $68.5 million in the FY2023 Labor, Health and Human Services, Education and Related Agencies Appropriations bill.
April 18, 2022, coalition letter addressed to Chair Murray and Ranking Member Blunt advocating for increasing funding for the CDC Office on Smoking Health by $68.5 million in the FY2023 Labor, Health and Human Services, Education and Related Agencies Appropriations bill.
June 14, 2022, coalition letter addressed to Chair Bishop and Ranking Member Harris advocating that the FY2023 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations bill not include provisions that would weaken FDA's authority over tobacco products.
Issues pertaining to tobacco control, in general.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Maura |
Farrell |
|
|
|
Thomas |
Radder |
|
|
|
Christopher |
Stewart |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
April 5, 2022, coalition letter to VA Secretary McDonough providing feedback to a proposed rule regarding the VA Pilot Program on Graduate Medical Education and Residency and implementing provisions of the 2018 Mission Act.
Issues pertaining to healthcare practice and the Federal Supremacy Clause at the Department of Veterans Affairs, in general.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Veterans Affairs - Dept of (VA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Christopher |
Stewart |
|
|
|
Maura |
Farrell |
|
|
|
Thomas |
Radder |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
| Lobbyist Name | Description of Offense(s) |